5.075
price down icon9.34%   -0.495
 
loading

Rezolute Inc Borsa (RZLT) Ultime notizie

pulisher
07:24 AM

What is the investor’s view on Rezolute Inc (RZLT)? - US Post News

07:24 AM
pulisher
07:14 AM

Rezolute (NASDAQ:RZLT) Rating Increased to Strong-Buy at Craig Hallum - MarketBeat

07:14 AM
pulisher
Feb 05, 2025

The Attractiveness of Investing In Rezolute Inc (RZLT) is Growing - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

H.C. Wainwright reiterates Buy on Rezolute shares, $14 target - Investing.com India

Feb 05, 2025
pulisher
Feb 05, 2025

Rezolute's (RZLT) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Feb 05, 2025
pulisher
Feb 05, 2025

JPMorgan Chase & Co. Purchases New Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Rezolute Advances SunRIZE Study for Hypoglycemia Treatment - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

Rezolute's ersodetug advances in pediatric study - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism - Marketscreener.com

Feb 04, 2025
pulisher
Feb 04, 2025

Clinical Trial Breakthrough: Rezolute's Rare Disease Drug Shows Promise in Vulnerable Infant Population - StockTitan

Feb 04, 2025
pulisher
Feb 04, 2025

Rezolute (RZLT) Projected to Post Earnings on Tuesday - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference -February 03, 2025 at 09:06 am EST - Marketscreener.com

Feb 03, 2025
pulisher
Feb 02, 2025

(RZLT) Trading Report - Stock Traders Daily

Feb 02, 2025
pulisher
Jan 31, 2025

Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference - The Manila Times

Jan 31, 2025
pulisher
Jan 31, 2025

Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference -January 31, 2025 at 08:01 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Rare Disease Pioneer Rezolute Takes Center Stage at Elite Guggenheim Biotech Conference - StockTitan

Jan 31, 2025
pulisher
Jan 27, 2025

Rezolute receives breakthrough therapy designation for treatment of hypoglycemia - MSN

Jan 27, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Predicts Rezolute FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 18, 2025

Rezolute, Inc. (NASDAQ:RZLT) Receives $24.13 Average Target Price from Analysts - Defense World

Jan 18, 2025
pulisher
Jan 15, 2025

Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $24.13 - MarketBeat

Jan 15, 2025
pulisher
Jan 14, 2025

Rezolute shares Phase 2 clinical study update By Investing.com - Investing.com South Africa

Jan 14, 2025
pulisher
Jan 14, 2025

Rezolute shares Phase 2 clinical study update - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

Rezolute Highlights Promising Phase 2 Ersodetug Results - TipRanks

Jan 14, 2025
pulisher
Jan 11, 2025

(RZLT) On The My Stocks Page - Stock Traders Daily

Jan 11, 2025
pulisher
Jan 08, 2025

Top 5 Small-cap Biotech Stocks (Updated January 2025) - Investing News Network

Jan 08, 2025
pulisher
Jan 08, 2025

Rezolute, Inc. (NASDAQ:RZLT) Shares Acquired by Geode Capital Management LLC - MarketBeat

Jan 08, 2025
pulisher
Jan 07, 2025

Rezolute Gains FDA Breakthrough Designation for Ersodetug - TipRanks

Jan 07, 2025
pulisher
Jan 07, 2025

Here's Why 'Trend' Investors Would Love Betting on Rezolute (RZLT) - Yahoo Finance

Jan 07, 2025
pulisher
Jan 07, 2025

FDA Grants Breakthrough Therapy Status to Rezolute's Ersodetug for Congenital Hyperinsulinism - StockTitan

Jan 07, 2025
pulisher
Jan 04, 2025

State Street Corp Acquires 13,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Jan 04, 2025
pulisher
Jan 02, 2025

Resolute Mining (LON:RSG) Stock Price Down 4.1% – Time to Sell? - Defense World

Jan 02, 2025
pulisher
Dec 31, 2024

CompoSecure to Spin-Off Resolute Holdings Management - citybiz

Dec 31, 2024
pulisher
Dec 30, 2024

CompoSecure Announces Strategic Spin-Off of Resolute Holdings Management, Targets Asset Management Growth - StockTitan

Dec 30, 2024
pulisher
Dec 28, 2024

MML Investors Services LLC Makes New $57,000 Investment in Rezolute, Inc. (NASDAQ:RZLT) - Defense World

Dec 28, 2024
pulisher
Dec 24, 2024

3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying - Yahoo Finance

Dec 24, 2024
pulisher
Dec 24, 2024

Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) Target Price at $24.13 - Defense World

Dec 24, 2024
pulisher
Dec 21, 2024

Rezolute, Inc. (NASDAQ:RZLT) Given Average Rating of "Buy" by Analysts - MarketBeat

Dec 21, 2024
pulisher
Dec 19, 2024

Rezolute CFO Daron Evans buys $42,900 in company stock By Investing.com - Investing.com Australia

Dec 19, 2024
pulisher
Dec 18, 2024

Rezolute CFO Daron Evans buys $42,900 in company stock - Investing.com India

Dec 18, 2024
pulisher
Dec 18, 2024

Insider Buying: Rezolute, Inc. (NASDAQ:RZLT) CFO Buys 10,000 Shares of Stock - MarketBeat

Dec 18, 2024
pulisher
Dec 13, 2024

Rezolute's SWOT analysis: biotech stock's pipeline progress and market potential - Investing.com Nigeria

Dec 13, 2024
pulisher
Dec 13, 2024

Rezolute's SWOT analysis: biotech stock's pipeline progress and market potential By Investing.com - Investing.com South Africa

Dec 13, 2024
pulisher
Dec 13, 2024

Chief Financial Officer of Rezolute Daron Evans Buys 6.5% More Shares - Simply Wall St

Dec 13, 2024
pulisher
Dec 12, 2024

Rezolute (NASDAQ:RZLT) and BetterLife Pharma (OTCMKTS:PVOTF) Head to Head Comparison - Defense World

Dec 12, 2024
pulisher
Dec 11, 2024

When the Price of (RZLT) Talks, People Listen - Stock Traders Daily

Dec 11, 2024
pulisher
Dec 10, 2024

Rezolute expands authorized shares following shareholder approval - Investing.com

Dec 10, 2024
pulisher
Dec 10, 2024

Daron Evans, CFO of Rezolute, buys $53,166 in common shares By Investing.com - Investing.com Nigeria

Dec 10, 2024
pulisher
Dec 10, 2024

Daron Evans, CFO of Rezolute, buys $53,166 in common shares - Investing.com

Dec 10, 2024
pulisher
Dec 09, 2024

Resolute Investment Managers Recognized in Pensions & Investments’ Best Places to Work in Money Management for Sixth Consecutive Year - Business Wire

Dec 09, 2024
pulisher
Dec 05, 2024

RZLT Stock Rises on FDA's Orphan Designation for Rare Disease Drug - MSN

Dec 05, 2024
pulisher
Dec 05, 2024

Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 05, 2024
$81.34
price up icon 0.43%
$20.78
price up icon 0.78%
$355.36
price up icon 1.17%
$5.11
price up icon 1.77%
biotechnology ONC
$232.53
price up icon 3.65%
$122.38
price up icon 4.47%
Capitalizzazione:     |  Volume (24 ore):